FY26 Financial Results

Mayank Cattle Food Ltd announced its audited financial results for the full year ended March 31, 2026, on May 11, 2026. The company reported revenue from operations of ₹403.17 crore, marking a 3.15% increase compared to the previous fiscal year. Profit for continuing operations saw a substantial jump of 21.13%, reaching ₹6.02 crore in FY26. The auditor's report on these financials was unmodified.

IPO Fund Reallocation

A key development noted in the filing is the shareholder-approved reallocation of ₹74.17 lakh from the company's Initial Public Offer (IPO) proceeds. These funds were originally earmarked for capital expenditure, specifically for acquiring plant and machinery. Shareholders approved shifting these funds to working capital needs on September 25, 2025. This move suggests a focus on immediate operational liquidity or a change in investment priorities.

Company Background and IPO

Mayank Cattle Food specializes in manufacturing and marketing cattle feed, poultry feed, and pet food. The company raised approximately ₹35 crore through its IPO in September 2023. The initial allocation of these IPO funds was intended for capacity expansion, debt repayment, and working capital requirements.

Investor Implications

The company's performance shows growth in revenue and profit, indicating increasing demand for its products and effective management. However, the reallocation of IPO funds from planned capital expenditure to working capital warrants investor attention. This shift could impact the company's long-term investment strategy and future expansion plans, while potentially strengthening short-term cash flow.

Industry Peers

In the broader agricultural sector, Mayank Cattle Food operates alongside diversified players like Godrej Agrovet Ltd, a significant entity in the animal feed market. Heranba Industries Ltd, involved in agrochemicals and animal health products, also operates within the wider agricultural value chain.

Key Figures

• Revenue from operations: ₹40,316.70 lakh (FY26 vs FY25)
• Profit for continuing operations: ₹601.81 lakh (FY26 vs FY25)
• Reallocated IPO funds (to working capital): ₹74.17 lakh

Future Focus

Investors will likely look for management's detailed explanations regarding the IPO fund reallocation during upcoming investor calls. Key areas to monitor include future capital expenditure plans, the impact of raw material cost trends on margins, progress on market expansion, and the overall demand dynamics in India's animal nutrition sector.